Posted on

Levothyroxine News from Europe

Levothyroxine News While we often report about the US laws relating to research chemicals this time we have ventured further afield to see what goes in Europe! The levothyroxine news from European Medicines Agency was announced that the drug would only be available for 2019. This has caused upset for sufferers and controversy over the change in formulation and the side effects continue.

The Story of Levothyroxine for sale

The old Levothyrox (Euthyrox) formula has continued to be offered to patients with hypothyroidism throughout 2019, according to a statement from the National Medicines Safety Agency (ANSM). “The ANSM asked the Merck laboratory to continue its availability in France the past year to allow patients still treated with Euthyrox to adapt to a new treatment,” said the press release, which specifies that the drug will be available only for a limited time and in limited quantities.

The news went on to say “the same numbers of boxes as in 2018, that is to say, 50,000 per month were bought,” said Valérie Leto, head pharmacist of the Merck laboratory. In total, between 3 and 4 million boxes of levothyroxine-based specialties are sold each month, all brands combined. “We have already imported Euthyrox from Germany since October 2017, at the request of the French health authorities,” continues Valérie Leto.

In Brief Hypothyroidism Causes?

Hypothyroidism is also known as low thyroid or underactive thyroid. It is a disorder that affects the endocrine system in the thyroid gland. This means the thyroid gland doesn’t make enough thyroid hormones. Therefore Hypothyroidism symptoms can cause problems such as constipation, depression, tiredness, poor ability to cope with the cold and weight gain.

Buy Levothyroxine is scheduled to End

The announcement was welcomed by the association “Living without thyroid”, which evokes a “breath of fresh air for patients who do not support the new formula”. As a reminder, the active principle (the hormone levothyroxine) remains the same, only the excipients differ. But the measure is still deemed insufficient: “This postpones the problem. What is needed is a sustainability of the two formulas side by side, “said Beate Bartès, president of” Living without thyroid “, at the AFP.

Where can I buy Levothyroxine Over The Counter?

However, the end of the old Levothyrox formula is already scheduled. The change was already made in Switzerland in April 2018 and other European countries are preparing to follow suit. “21 European countries have approved the marketing of the new formula,” explains Valérie Leto. From the start of 2019, it was to be Germany’s turn. “The boxes of Euthyrox supplying the French circuit will therefore no longer be imported from Germany but from “another European country”.”The product will be strictly the same,” said the Merck pharmacist.

Levothyroxine tablet buy online – ways to understand the crisis the 5 drugs available

In addition, the offer has diversified widely since the end of 2018, at the request of the Minister of Health Agnès Buzyn. While Merck was until then one of the only two laboratories to market a drug based on levothyroxine (with the drug in oral solution from the Serb laboratory), three alternatives are now available: L-Thyroxin Henning (Sanofi), Tcaps (Juniper laboratory) and Thyrofix (Serb laboratory).

Levothyroxine Mechanism of Action

On the side of “Living without thyroid”, it is estimated that the reasons for the change of formulation remain unclear. “The authorities say that the old product does not meet the new specifications and that it was absolutely impossible to continue,” said the president of the association. It is to respond to a request from the French Medicines Agency dated 2012 that the Merck laboratory has changed the formulation.

“The active ingredient degrades overtime on contact with the excipient, which means that the drug does not meet the standards for stability and American regulations on dosages,” said Valérie Leto. “This could lead to differences in dosages from one batch to another but also between the different drugs on the market.”

In 2012, the ANSM, therefore, asked the Merck laboratory, but also the two other laboratories which marketed a generic medicine, to comply with the more stringent standards set down by the American health authorities. “We are the only laboratory to have done so, we have committed more than 30 million Euros,” points out Valérie Leto. By nature, we were left alone in the market, but it is not a wanted monopoly. ”

Future Levothyrox News

“The patent for the old formula expired in May 2019. While the new formula has a patent for 2014 which lasts until 2034,” says Beate Bartès. Information confirmed in Figaro by the Merck laboratory, denies any link between the change in formula and financial interests.

“When the ANSM asked us to make the change, it notified us that if we did not change the formula, we would withdraw the marketing authorization, says Florent Bensadoun, legal director of the Merck group in France. Patent Helps Protect Our Work, Not Prevent Competitors.

Levothyroxine for sale

This news concludes that chemical levothyroxine is still needed but needs more research to get the right treatment for patients with this disorder.  Levothyroxine news in the US is that the ingredient is still being studied and this will continue. This is not for human consumption. But, if you are in the research industry check out Peptides USA stock now and levothyroxine 100 mg buy online!